TY - JOUR T1 - Global Monitoring of the Impact of COVID-19 Pandemic through Online Surveys Sampled from the Facebook User Base JF - medRxiv DO - 10.1101/2021.07.05.21259989 SP - 2021.07.05.21259989 AU - Christina M. Astley AU - Gaurav Tuli AU - Kimberly A. Mc Cord - De Iaco AU - Emily L. Cohn AU - Benjamin Rader AU - Samantha Chiu AU - Xiaoyi Deng AU - Kathleen Stewart AU - Tamer H. Farag AU - Kris M. Barkume AU - Sarah LaRocca AU - Katherine A. Morris AU - Frauke Kreuter AU - John S. Brownstein Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/07/07/2021.07.05.21259989.abstract N2 - Simultaneously tracking the global COVID-19 impact across multiple populations is challenging due to regional variation in resources and reporting. Leveraging self-reported survey outcomes via an existing international social media network has the potential to provide reliable and standardized data streams to support monitoring and decision-making world-wide, in real time, and with limited local resources. The University of Maryland Global COVID Trends and Impact Survey (UMD-CTIS), in partnership with Facebook, invites daily cross-sectional samples from the social media platform’s active users to participate in the survey since launch April 23, 2020. COVID-19 indicators through December 20, 2020, from N=31,142,582 responses representing N=114 countries, weighted for nonresponse and adjusted to basic demographics, were benchmarked with government data. COVID-19-related signals showed similar concordance with reported benchmark case and test positivity. Bonferroni significance and minimal Spearman correlation strength thresholds were met in the majority. Light Gradient Boost machine learning trained on national and pooled global data verified known symptom indicators, and predicted COVID-19 trends similar to other signals. Risk mitigation behavior trends are correlated with, but sometimes lag, risk perception trends. In regions with strained health infrastructure, but active social media users, we show it is possible to define suitable COVID-19 impact trajectories. This syndromic surveillance public health tool is the largest global health survey to date, and, with brief participant engagement, can provide meaningful, timely insights into the COVID-19 pandemic and response in regions under-represented in epidemiological analyses.Significance Statement The University of Maryland Global COVID Trends and Impact Survey (UMD-CTIS), launched April 23, 2020, is the largest remote global health monitoring system. This study includes about 30 million UMD-CTIS responses over 34 weeks (through December 2020) from N=114 countries with survey-weights to adjust for nonresponse and demographics. Using limited self-reported data, sampled daily from an international cohort of Facebook users, we demonstrate validity and utility for COVID-19 impacts trends, even in regions with scant or delayed government data. We predict COVID-19 cases in the absence of testing, and characterize perceived COVID-19 risk versus risk-lowering measures. The UMD-CTIS has the potential to support existing monitoring systems for the COVID-19 pandemic, as well as other new, as-yet-undefined global health threats.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialRetrospective analysis of prospectively collected cross-sectional surveys. This is not a clinical trial.Funding StatementFacebook Sponsored Research Agreement INB1116217 (CMA, JSB, ELC, BR, GT and KAM (Mc Cord - De Iaco)). Facebook, Inc. Grant No. 4332732 (SLC, XD, KS, FK).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This research is based on survey results from UMD-CTIS, approved by the UMD Institutional Review Board (IRB, 1587016-10). This study was approved by the BCH IRB (P00023700).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymous responses and survey weights are processed at the University of Maryland, which also oversees survey content. Aggregated data are released to the public in near-real-time. Researchers may apply to use raw micro-data to study COVID-19 through a Data Use Agreement (https://covidmap.umd.edu/fbsurvey/) https://covidmap.umd.edu/fbsurvey/ ER -